30 results on '"Dias de Castro F"'
Search Results
2. P161 Simplified Endoscopic Mucosal Assessment for Crohn’s Disease (SEMA-CD): External Application and Prognostic Value Definition
3. P182 Modified Multiplier SES-CD (MM-SES-CD) and laboratorial Crohn’s disease activity parameters: is there any association?
4. P567 How can we predict the development of antibodies to infliximab in Crohn’s disease?
5. P551 Platelet-to-lymphocyte ratio index for non-invasive assessment of endoscopic activity in small bowel Crohn’s disease: application and prospective validation
6. P205 Eliakim and CECDAIic scores are useful pan-intestinal tools for CD diagnosis and activity monitoring
7. P158 Disease and non-disease-related risk factors for inadequate bowel preparation in patients with inflammatory bowel disease: should the strategy be different?
8. P354 Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
9. P145 Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective study
10. P138 Platelet-to-lymphocyte ratio index: a reliable tool for non-invasive assessment of endoscopic activity in small bowel Crohn’s Disease
11. P196 Colon-involving versus non-colon-involving Crohn’s disease classification: is the Montreal classification outdated?
12. P134 Ultrasonographic scores for Crohn’s disease activity assessment – still lag behind CEUS
13. P595 Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel disease
14. P492 Use of bowel ultrasound to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
15. P562 5-ASA in ulcerative colitis: Are they really needed in the biological therapy era?
16. P168 Isolated terminal ileitis: when capsule endoscopy is key for Crohn’s disease diagnosis
17. P734 Should we have a higher threshold for anti-TNF serum levels in Crohn’s disease patients with perianal disease?
18. P251 Small bowel capsule endoscopy is a valuable diagnostic tool in isolated terminal ileitis
19. P551 Combination therapy in IBD Patients: Do we need to maximise the dose of Azathioprine?
20. P231 CECDAIic: a new score for panenteric evaluation in Crohn’s disease patients
21. P175 Capsule endoscopy for small bowel Crohn’s disease—should we trust in magnetic resonance enterography?
22. P142 Ulcerative colitis: risk factors for relapse in clinical remission patients
23. P324 Tuberculosis infection under anti-TNF therapy – should we be looking for it?
24. P104 Monitoring inflammatory activity in Crohn’s disease: simple ultrasonographic score vs. CEUS which one to use?
25. P311 Crohn’s disease: What can we expect from the course of the disease?
26. P198 Are lower levels of faecal calprotectin reassuring in Crohn′s Disease patients?
27. P252 Assessment of ulcerative colitis using histological indexes
28. P136 Sporadic adenomas in IBD patients over 50 years old and average risk population – Is there a difference?
29. P472 Original and biosimilar infliximab: Are they two faces of the same coin? The experience from a pioneer European center
30. Lewis Score – Prognostic Value in Patients with Isolated Small Bowel Crohn’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.